Trial Profile
Phase I trial of BMS 751324, a p38 kinase inhibitor for the treatment of rheumatoid arthritis
Status:
Not stated
Phase of Trial:
Phase I
Latest Information Update: 05 May 2014
Price :
$35
*
At a glance
- Drugs BMS 751324 (Primary)
- Indications Rheumatoid arthritis
- Focus Adverse reactions
- Sponsors Bristol-Myers Squibb
- 01 Feb 2006 New trial record.